Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.91USD
22 Aug 2014
Price Change (% chg)

$0.01 (+0.82%)
Prev Close
$0.90
Open
$0.88
Day's High
$0.92
Day's Low
$0.87
Volume
44,363
Avg. Vol
111,078
52-wk High
$2.23
52-wk Low
$0.81

ACUR.O

Chart for ACUR.O

About

Acura Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and... (more)

Overall

Beta: 1.70
Market Cap (Mil.): $44.45
Shares Outstanding (Mil.): 48.85
Dividend: --
Yield (%): --

Financials

  ACUR.O Industry Sector
P/E (TTM): -- 139.05 34.44
EPS (TTM): -0.29 -- --
ROI: -71.24 -2.96 18.11
ROE: -92.54 -7.10 18.84
Search Stocks

FDA seeks more data on Acura's abuse-resistant pain drug

- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.

15 Aug 2014

FDA seeks more data on Acura's abuse-resistant pain drug

Aug 15 - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.

15 Aug 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks